WOONSOCKET -
The Company will not be hosting a conference call to discuss the results. The Company intends to hold the previously-announced special shareholders meeting ('Meeting') on
About
Abacus is principally engaged in the development and commercialization of over-thecounter (OTC) topical medications with active pharmaceutical ingredients and which contain organic and natural ingredients, including a cannabinoid-rich hemp extract containing CBD from the Cannabis sativa L plant. Abacus' products are aimed at the rapidly growing markets for topical pain relief and therapeutic skincare and are based on proprietary patent-pending technologies developed by Abacus. Abacus' formulations combine advanced science with organic and natural ingredients to provide safe relief. Abacus currently offers three lines of products: CBD CLINIC, marketed to the professional practitioner market, and CBDMEDIC and
Contact:
Tel: 1.416.479.9547
Email: bill@abacushp.com
(C) 2020 Electronic News Publishing, source